XML 30 R32.htm IDEA: XBRL DOCUMENT v2.4.0.6
STOCK-BASED COMPENSATION (Details 2) (USD $)
Share data in Thousands, except Per Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Jul. 29, 2012
Jul. 31, 2011
Jul. 29, 2012
Y
Jul. 31, 2011
Stock-based compensation expense, along with the related income tax benefit        
Stock based compensation expense recognized $ 3,062,000 $ 2,578,000 $ 14,191,000 $ 14,820,000
Income tax benefit recognized (1,161,000) (979,000) (5,381,000) (5,629,000)
After-tax stock-based compensation expense 1,901,000 1,599,000 8,810,000 9,191,000
Stock-based compensation expense unrecognized 14,000,000   14,000,000  
Period for recognition of unrecognized stock-based compensation expense (in years)     2.7  
Stock options
       
Stock-based compensation        
Cash received from stock options exercised 3,900,000 6,800,000 13,900,000 50,500,000
Tax benefit realized from stock options, aggregate 3,000,000 4,200,000 8,800,000 19,100,000
Reconciliation of Stock Options        
Outstanding, at the beginning of the period (in shares)     19,932  
Granted (in shares)     2,642  
Exercised (in shares)     1,612  
Forfeited (in shares)     33  
Outstanding, at the end of the period (in shares) 20,929   20,929  
Exercisable at the end of the period (in shares) 14,504   14,504  
Weighted Average Exercise Price        
Outstanding at the beginning of the period (in dollars per share)     $ 17.89  
Granted (in dollars per share) $ 29.42   $ 29.42  
Exercised (in dollars per share) $ 15.07   $ 15.07  
Forfeited (in dollars per share) $ 21.29   $ 21.29  
Outstanding at the end of the period (in dollars per share) $ 19.55   $ 19.55  
Exercisable at end of period (in dollars per share) $ 17.38   $ 17.38  
Weighted Average Remaining Contractual Term        
Outstanding at the end of the period (in years) 5.7   5.7  
Exercisable at end of period (in years)     4.5  
Aggregate Intrinsic Value        
Outstanding at the end of the period 187,817,000   187,817,000  
Exercisable at end of period 159,846,000   159,846,000  
Weighted-average grant date fair value of stock options granted, and the total intrinsic value of options exercised        
Weighted-average grant date fair value of options granted (in dollars per share)     $ 5.64 $ 5.54
Intrinsic value of exercised options 8,011,000 11,124,000 23,332,000 50,312,000
Weighted-average assumptions used to calculate fair value of each ordinary option award        
Risk free interest rate (as a percent)     1.80% 3.00%
Expected Dividend Rate (as a percent)     2.00% 2.00%
Expected stock price volatility rate (as a percent)     21.00% 21.00%
Expected Option Life (in years)     8 8
Nonvested shares
       
Reconciliation of the nonvested shares        
Nonvested shares at the beginning of the period     215  
Nonvested shares granted in period     45  
Nonvested shares vested in period     110  
Nonvested shares Forfeited in period     7  
Nonvested shares at the end of the period 143   143  
Weighted-average grant date fair value and total fair value of nonvested shares granted, vested and forfeited        
Nonvested shares at the beginning of the period (in dollars per share)     $ 19.94  
Nonvested shares granted in period (in dollars per share)     $ 28.97 $ 24.84
Nonvested shares vested in period (in dollars per share)     $ 21.13  
Nonvested shares Forfeited in period (in dollars per share) $ 28.27   $ 28.27  
Nonvested shares at the end of the period (in dollars per share) $ 21.48   $ 21.48  
Fair value of nonvested shares granted     1,304,000 1,118,000
Fair value of shares vested     $ 2,324,000 $ 335,000